Skip to main content
. 2019 Jul 9;12:5485–5497. doi: 10.2147/OTT.S197009

Figure 3.

Figure 3

DANCR directly targeted miR-34a-5p. (A) The putative binding sites of DANCR in miR-34a-5p were predicted using DIANA-LncBase software. (B and C) Luciferase activity of wild-type or mutant DANCR in DU145/DTX and PC3/DTX cells following miR-NC or miR-34a-5p transfection was determined by luciferase reporter assay. (D) The correlation between DANCR and miR-34a-5p in DU145/DTX and PC3/DTX cells was detected by RNA immunoprecipitation (RIP) assay. (E and F) The direct interaction between DANCR and miR-34a-5p was assessed by RNA pull-down assay. (G) The miR-34a-5p level in DTX-sensitive or DTX-resistant PC cells was detected by qRT-PCR. (H and I) The expression of DANCR and miR-34a-5p in DU145/DTX and PC3/DTX cells, which were initially transfected with pcDNA, pcDNA-DANCR, si-NC, or si-DANCR, was determined by qRT-PCR assay. *p<0.05.

Abbreviations: DANCR, anti-differentiation noncoding RNA; DTX, docetaxel; MUT, mutant; PC, prostate cancer; qRT-PCR, quantitative reverse transcription PCR; si-DANCR, small interfering RNA targeting DANCR; WT, wild type.